Home > News > Purdue will launch first medication-error investigation program in U.S.
January 9th, 2007
Purdue will launch first medication-error investigation program in U.S.
Abstract:
As a model, the medication-error response team will use Purdue's Technical Assistance Program, which links Indiana companies with Purdue resources, to establish a pharmaceutical technical assistance program. Purdue researchers also will develop systems, much like those currently found in industry, to reduce medication errors.
A leader in industrial pharmacy, Purdue also will use the Lilly Endowment investment to focus on reducing the cost and time needed to develop drugs. Nanotechnology will be used to develop delivery systems for cancer drugs to help reduce their toxicity.
Source:
pharmalive.com
Bookmark:
| Related News Press |
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
Human Interest/Art
New 2D multifractal tools delve into Pollock's expressionism January 17th, 2025
Drawing data in nanometer scale September 30th, 2022
Scientists prepare for the world’s smallest race: Nanocar Race II March 18th, 2022
Graphene nanotubes revolutionize touch screen use for prosthetic hands August 3rd, 2021
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||